Jai Nagarkatti, David Harvey, Avi Nash, Arnold Pinkston, William May, Dmitry Samarsky, Bruker BioSciences, Harvard Bio, PerkinElmer, GE Healthcare, Applied Biosystems, Thermo, Fisher, Beckman | GenomeWeb


Jai Nagarkatti has been promoted to CEO of Sigma-Aldrich, effective Jan. 1, 2006, and will become a member of the board of directors. He is currently president and COO, and will retain the title of president. He succeeds Chairman and CEO David Harvey, who will remain on the board of directors. Nagarkatti has been employed by Sigma-Aldrich for 29 years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.